Cancer UrologyCancer UrologyОнкоурология1726-97761996-1812Publishing House ABV Press9510.17650/1726-9776-2013-9-2-57-62PROSTATE CANCERРАК ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫRADICAL RETROPUBIC PROSTATECTOMY: THE FIRST RUSSIAN EXPERIENCE OF 15-YEAR FOLLOW-UP AFTER SURGERYРАДИКАЛЬНАЯ ПОЗАДИЛОННАЯ ПРОСТАТЭКТОМИЯ: ПЕРВЫЙ РОССИЙСКИЙ ОПЫТ 15-ЛЕТНЕГО НАБЛЮДЕНИЯ ПОСЛЕ ОПЕРАЦИИVelievE. I.ВелиевЕ. И.
Russian Federation

Department of Urology and Surgical Andrology

кафедра урологии и хирургической андрологии

egsok@bk.ruPetrovS. B.ПетровС. Б.
Russian Federation
egsok@bk.ruLoranO. B.ЛоранО. Б.
Russian Federation

Department of Urology and Surgical Andrology

кафедра урологии и хирургической андрологии

egsok@bk.ruSokolovE. A.СоколовЕ. А.
Russian Federation

Department of Urology and Surgical Andrology

кафедра урологии и хирургической андрологии

egsok@bk.ruSereginA. V.СерегинА. В.
Russian Federation

Department of Urology and Surgical Andrology

кафедра урологии и хирургической андрологии

egsok@bk.ruLukyanovI. V.ЛукьяновИ. В.
Russian Federation

Department of Urology and Surgical Andrology

кафедра урологии и хирургической андрологии

egsok@bk.ruRussian Medical Academy of Postgraduate Education, Ministry of Health of the Russian Federation, MoscowГБОУ ДПО РМАПО МЗ РФ, МоскваA.M. Nikiforov All-Russian Center of Emergency and Radiation Medicine, Ministry of Emergency Situations of the Russian Federation, Saint PetersburgФГБУ «Всероссийский центр экстренной и радиационной медицины им. А.М. Никифорова» МЧС РФ, Санкт-Петербург300620139257622707201427072014https://oncourology.abvpress.ru/oncur/article/view/95

The results of the maximum of more than 15 years of follow-up of Russia’s first large series of patients after radical retropubic prostatectomy (RPE) were traced. The data of 1367 patients who had undergone RPE at the Clinic of Urology, S.P. Kirov Military Medical Academy, in 1997 to 2003 and at the Clinic of Urology, Russian Medical Academy of Postgraduate Education, in 2001 to 2010 were retrospectively studied. After excluding 626 patients who had an incomplete set of preoperative/postoperative characteristics, a postoperative follow-up of < 6 months, neoadjuvant hormonal or radiation therapy, the trial included 741 patients. Their median age at surgery was 64 years (interquartile range (IQR): 59-68); median prostatespecific antigen (PSA), 8.7 ng/ml (IQR: 6.2-14); median follow-up, 65 months (IQR: 50-87; the maximum follow-up period, 189 months). Out of the 741 patients, 30.2, 28.3, and 41.5% were referred to as D’Amico classification low-, moderate-, and high-risk groups, respectively. Five-, 10-, and 15-year relapse-free survival rates were 80.3, 74.7, and 66.7%; 5-, 10-, and 15-year cancer-specific survival rates were 98.3, 95.9, and 85.7%; and 5-, 10-, and 15-year overall survival rates were 92.5, 81.4, and 64.3%, respectively. The significant predictors of biochemical recurrence were a preoperative PSA level of 10.1–20 ng/ml (p = 0.041), > 20 ng/ml (p = 0.003); pathological stage pT3b–4N0 (p = 0.006) and any stage pT N1 (p = 0.003). Further investigations are needed to identify groups of patients who will have the most benefit from surgery.

prostate cancerradical prostatectomybiochemical recurrencesurvivalрак предстательной железырадикальная простатэктомиябиохимический рецидиввыживаемость1. Bosetti C., Bertuccio P., Chatenoud L. et al. Trends in mortality from urologic cancers in Europe, 1970–2008. Eur Urol 2011;60:1–15.Bosetti C., Bertuccio P., Chatenoud L. et al. Trends in mortality from urologic cancers in Europe, 1970–2008. Eur Urol 2011;60:1–15.2. Чиссов В.И., Русаков И.Г. Заболеваемость раком предстательной железы в Российской Федерации. Экспериментальная и клиническая урология 2011;(2–3):6–7.Чиссов В.И., Русаков И.Г. Заболеваемость раком предстательной железы в Российской Федерации. Экспериментальная и клиническая урология 2011;(2–3):6–7.3. Салищев Э.Г. Полное иссечение предстательной железы с нижними частями семенных пузырьков и двух нижних третей прямой кишки при раке их. Хирургическая летопись 1896, №5.Салищев Э.Г. Полное иссечение предстательной железы с нижними частями семенных пузырьков и двух нижних третей прямой кишки при раке их. Хирургическая летопись 1896, №5.4. Young H.H. Conservative perineal prostatectomy: the results of two years experience and report of seventy-five cases. Ann Surg 1905;41:549–557.Young H.H. Conservative perineal prostatectomy: the results of two years experience and report of seventy-five cases. Ann Surg 1905;41:549–557.5. Millin T. Retropubic prostatectomy. J Urol 1948;59:267–74.Millin T. Retropubic prostatectomy. J Urol 1948;59:267–74.6. Reiner W.G., Walsh P.C. An anatomical approach to the surgical management of the dorsal vein and Santorini’s plexus during radical retropubic surgery. J Urol 1979;121:198–200.Reiner W.G., Walsh P.C. An anatomical approach to the surgical management of the dorsal vein and Santorini’s plexus during radical retropubic surgery. J Urol 1979;121:198–200.7. Walsh P.C., Donker P.J. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982;128:492–7.Walsh P.C., Donker P.J. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982;128:492–7.8. Oelrich T.M. The urethral sphincter muscle in the male. Am J Anat 1980;158:229–46.Oelrich T.M. The urethral sphincter muscle in the male. Am J Anat 1980;158:229–46.9. Walsh P.C., Lepor H., Eggleston J.C. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983;4:473–85.Walsh P.C., Lepor H., Eggleston J.C. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983;4:473–85.10. Walsh P.C., Partin A.W., Epstein J.I. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994;152:1831–6.Walsh P.C., Partin A.W., Epstein J.I. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994;152:1831–6.11. Mullins J.K., Feng Z., Trock B.J. et al. The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary. J Urol 2012;188:219–24.Mullins J.K., Feng Z., Trock B.J. et al. The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary. J Urol 2012;188:219–24.12. D’Amico A.V., Whittington R., Malkowicz B.S. et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1988;280:969–74.D’Amico A.V., Whittington R., Malkowicz B.S. et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1988;280:969–74.13. Han M., Partin A.W., Pound C.R. et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001;28:555–65.Han M., Partin A.W., Pound C.R. et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001;28:555–65.14. Roehl K.A., Han M., Ramos C.G. et al. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol 2004;172:910–4.Roehl K.A., Han M., Ramos C.G. et al. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol 2004;172:910–4.15. Kim S.C., Jeong I., Song C. et al. Biochemical recurrence-free and cancer-specific survival after radical prostatectomy at a single institution. Korean J Urol 2010;51:836–42.Kim S.C., Jeong I., Song C. et al. Biochemical recurrence-free and cancer-specific survival after radical prostatectomy at a single institution. Korean J Urol 2010;51:836–42.16. Roder M.A., Berg K.D., Gruschy L. et al. First Danish single-institution experience with radical prostatectomy: biochemical outcome in 1200 consecutive patients. Prostate Cancer 2011, 2011: doi:10.1155/2011/236357.Roder M.A., Berg K.D., Gruschy L. et al. First Danish single-institution experience with radical prostatectomy: biochemical outcome in 1200 consecutive patients. Prostate Cancer 2011, 2011: doi:10.1155/2011/236357.17. Черняев В.А., Матвеев В.Б., Волков а М.И. и др. Факторы прогноза биохимического рецидива локализованного и местно-распространенного рака простаты после радикальной простатэктомии. Онкоурология 2012;4:58–64.Черняев В.А., Матвеев В.Б., Волков а М.И. и др. Факторы прогноза биохимического рецидива локализованного и местно-распространенного рака простаты после радикальной простатэктомии. Онкоурология 2012;4:58–64.18. D’Amico A.V., Whittington R., Malkowicz S.B. et al. Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol 2001;166:2185–8.D’Amico A.V., Whittington R., Malkowicz S.B. et al. Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol 2001;166:2185–8.19. Boorjian S.A., Karnes R.J., Rangel .LJ. et al. Mayo Clinic validation of the D’Amico risk group classification for predicting survival following radical prostatectomy. J Urol 2008;179:1354–61.Boorjian S.A., Karnes R.J., Rangel .LJ. et al. Mayo Clinic validation of the D’Amico risk group classification for predicting survival following radical prostatectomy. J Urol 2008;179:1354–61.20. Blute M.L., Bergstralh E.J., Iocca A. et al. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol 2001;165:119–25.Blute M.L., Bergstralh E.J., Iocca A. et al. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol 2001;165:119–25.21. Stephenson A.J., Scardino P.T., Eastham J.A. et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2005;23:7005–12.Stephenson A.J., Scardino P.T., Eastham J.A. et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2005;23:7005–12.22. Hull G.W., Rabbani F., Abbas F. et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002;167:528–34.Hull G.W., Rabbani F., Abbas F. et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002;167:528–34.23. Eifler J.B., Humphreys E.B., Agro M. et al. Causes of death after radical prostatectomy at a large tertiary center. J Urol 2012;188:798–802.Eifler J.B., Humphreys E.B., Agro M. et al. Causes of death after radical prostatectomy at a large tertiary center. J Urol 2012;188:798–802.